Zobrazeno 1 - 10
of 116
pro vyhledávání: '"M V Ezhov"'
Autor:
N A Tmoyan, M V Ezhov, O I Afanasieva, E A Klesareva, O A Razova, V V Kukharchuk, S N Pokrovsky
Publikováno v:
Терапевтический архив, Vol 90, Iss 9, Pp 31-36 (2018)
Aim. Lipoprotein(a) [Lp(a)] is an independent risk factor of coronary heart disease (CHD) and myocardial infarction. Data about the role of Lp(a) in the development of peripheral artery disease (PAD) is controversial and uncertain. The aim of the stu
Externí odkaz:
https://doaj.org/article/571a6907198c4d418542a6f7288024b5
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 5, Pp 566-573 (2024)
Hypertriglyceridemia (HTG) is associated with an increased risk of atherosclerotic cardiovascular disease, pancreatitis developing, and all-cause mortality. The risk escalates with rising triglyceride levels and is most significant in extreme HTG (tr
Externí odkaz:
https://doaj.org/article/8c9a3e44768a40d5a439002655b6fa03
Autor:
M. V. Ezhov, U. V. Chubykina
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 8 (2024)
Externí odkaz:
https://doaj.org/article/75bad3f41206416899af52bc1500520f
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 8 (2024)
Despite a variety of lipid-lowering drugs, mostly pelleted, aimed at reducing low-density lipoprotein cholesterol and triglycerides, only a small number of patients achieve their target levels. The reasons are insufficient adherence to treatment, rar
Externí odkaz:
https://doaj.org/article/e21b417a94c64b7eafa7fb8bb1d3ccda
Autor:
M V Ezhov, O I Afanas'eva, A A Kambegova, M I Afanas'eva, E P Trukhacheva, V G Naumov, S N Pokrovskiy, O I Afanasyeva, M I Afanasyeva, S N Pokrovsky
Publikováno v:
Терапевтический архив, Vol 81, Iss 5, Pp 50-53 (2009)
Aim. To determine distribution of different atherosclerosis risk factors and their correlation with severity of coronary arteries (CA) affection in young men. Material and methods. A total of 235 males aged 28-45 years were examined with coronarograp
Externí odkaz:
https://doaj.org/article/c18bf0b014a148d0ad4c64fcf5e00d5a
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4, Pp 108-119 (2024)
The federal program of preferential drug provision in cardiology shows its effectiveness. However, hypercholesterolemia (HCH) remains a significant problem in patients in whom high-dose statin therapy does not provide the target level of low-density
Externí odkaz:
https://doaj.org/article/393eef0942b94c26abf0f4c624ced547
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 2, Pp 143-150 (2023)
Aim. To study the frequency of prescriptions of various types of lipid-lowering therapy and their effectiveness in outpatient clinical practice based on the results of a questionnaire of primary care physicians.Material and methods. The study was per
Externí odkaz:
https://doaj.org/article/37d179a1ea3a412c8ae7ca9c442b1d30
Autor:
I. V. Sergienko, M. V. Ezhov
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 4S (2023)
The novelty of the 2023 National Guidelines for Lipid Metabolism Disorders is presented regarding the categorization of cardiovascular risk, target and optimal levels of blood lipids, diagnosis and therapeutic approaches to the treatment of dyslipide
Externí odkaz:
https://doaj.org/article/03a7cac463e04ac1a05c1becdea7484c
Autor:
M. M. Tanashyan, N. A. Shamalov, I. A. Voznyuk, S. N. Yanishevsky, O. I. Vinogradov, D. R. Khasanova, O. V. Tikhomirova, V. A. Parfenov, E. V. Oshchepkova, M. V. Ezhov, V. S. Gurevich, V. V. Arkhipov
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 4, Pp 108-113 (2022)
On July 6, 2022, an interdisciplinary meeting of the Expert Council was held on the topic "Control of dyslipidemia in the prevention of acute and recurrent ischemic cerebrovascular accidents". The conclusion of the Expert Council was that after verif
Externí odkaz:
https://doaj.org/article/5131cf7e37dc4328a08303b97dcf28e3
Autor:
M. V. Ezhov, V. V. Kukharchuk, I. V. Sergienko, A. S. Alieva, M. B. Antsiferov, A. A. Ansheles, G. G. Arabidze, D. M. Aronov, G. P. Arutyunov, N. M. Akhmedzhanov, T. V. Balakhonova, O. L. Barbarash, S. A. Boytsov, M. G. Bubnova, M. I. Voevoda, G. R. Galstyan, A. S. Galyavich, N. B. Gornyakova, V. S. Gurevich, I. I. Dedov, O. M. Drapkina, D. V. Duplyakov, S. Ya. Eregin, A. I. Ershova, O. B. Irtyuga, R. S. Karpov, Yu. A. Karpov, M. A. Kachkovsky, Zh. D. Kobalava, N. A. Koziolova, G. A. Konovalov, V. O. Konstantinov, E. D. Kosmacheva, Yu. V. Kotovskaya, A. I. Martynov, A. N. Meshkov, D. V. Nebieridze, S. V. Nedogoda, A. G. Obrezan, V. E. Oleinikov, S. N. Pokrovsky, Yu. I. Ragino, O. P. Rotar, V. V. Skibitsky, O. G. Smolenskaya, A. A. Sokolov, A. B. Sumarokov, E. Filippov, Yu. Sh. Halimov, I. E. Chazova, I. I. Shaposhnik, M. V. Shestakova, S. S. Yakushin, E. V. Shlyakhto
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 5 (2023)
The Russian Society of Cardiology (RKO)With the participation of: The National Society for the Study of Atherosclerosis (NOA), the Russian Association of Endocrinologists (RAE), the Russian Society of Cardiosomatic Rehabilitation and Secondary Preven
Externí odkaz:
https://doaj.org/article/74d801ab1b2e4d4c855890c00ec1b9f6